Novel Approaches in Pharmacological Therapy of Heart Failure: Supression of Neuroendocrihe and Immune Response

Volume: 28 Number: 3 September 1, 2002
  • Aysel Aydın
  • Uğur Yuvanç
  • Jale Cordan
EN TR

Novel Approaches in Pharmacological Therapy of Heart Failure: Supression of Neuroendocrihe and Immune Response

Abstract

Heart failure is a clinical syndrome in which the heart muscle is insufficient to supply the metabolic demands of the tissues due to its impaired neurohormonal state as well as functions. Today, by taking the physiopathology into consideration, the main aim of the therapy is to terminate chain reaction causing and exacerbating the heart failure. In working towards the aim stated above, it was shown in many large-scaled trails that the angiotensin-converting enzyme inhibitors and beta blockers, which are utilized as the first step in therapy, reduce mortality and morbidity rates. Angiotensin receptor blockers, endothelin receptor antagonists, neutral endopeptidase inhibitors, natriuretic peptides and immune suppressing agents showed beneficial effects in pilot trials, however their necessity is not clear. In this review, evidence based treatment of congestive heart failure and new approaches for the inhibition of neuroendocrine and immune responses were evaluated.

Keywords

Details

Primary Language

English

Subjects

-

Journal Section

-

Authors

Aysel Aydın This is me

Uğur Yuvanç This is me

Jale Cordan This is me

Publication Date

September 1, 2002

Submission Date

September 1, 2002

Acceptance Date

-

Published in Issue

Year 2002 Volume: 28 Number: 3

APA
Aydın, A., Yuvanç, U., & Cordan, J. (2002). Novel Approaches in Pharmacological Therapy of Heart Failure: Supression of Neuroendocrihe and Immune Response. Journal of Uludağ University Medical Faculty, 28(3), 115-120. https://izlik.org/JA77SW38JN
AMA
1.Aydın A, Yuvanç U, Cordan J. Novel Approaches in Pharmacological Therapy of Heart Failure: Supression of Neuroendocrihe and Immune Response. Journal of Uludağ University Medical Faculty. 2002;28(3):115-120. https://izlik.org/JA77SW38JN
Chicago
Aydın, Aysel, Uğur Yuvanç, and Jale Cordan. 2002. “Novel Approaches in Pharmacological Therapy of Heart Failure: Supression of Neuroendocrihe and Immune Response”. Journal of Uludağ University Medical Faculty 28 (3): 115-20. https://izlik.org/JA77SW38JN.
EndNote
Aydın A, Yuvanç U, Cordan J (September 1, 2002) Novel Approaches in Pharmacological Therapy of Heart Failure: Supression of Neuroendocrihe and Immune Response. Journal of Uludağ University Medical Faculty 28 3 115–120.
IEEE
[1]A. Aydın, U. Yuvanç, and J. Cordan, “Novel Approaches in Pharmacological Therapy of Heart Failure: Supression of Neuroendocrihe and Immune Response”, Journal of Uludağ University Medical Faculty, vol. 28, no. 3, pp. 115–120, Sept. 2002, [Online]. Available: https://izlik.org/JA77SW38JN
ISNAD
Aydın, Aysel - Yuvanç, Uğur - Cordan, Jale. “Novel Approaches in Pharmacological Therapy of Heart Failure: Supression of Neuroendocrihe and Immune Response”. Journal of Uludağ University Medical Faculty 28/3 (September 1, 2002): 115-120. https://izlik.org/JA77SW38JN.
JAMA
1.Aydın A, Yuvanç U, Cordan J. Novel Approaches in Pharmacological Therapy of Heart Failure: Supression of Neuroendocrihe and Immune Response. Journal of Uludağ University Medical Faculty. 2002;28:115–120.
MLA
Aydın, Aysel, et al. “Novel Approaches in Pharmacological Therapy of Heart Failure: Supression of Neuroendocrihe and Immune Response”. Journal of Uludağ University Medical Faculty, vol. 28, no. 3, Sept. 2002, pp. 115-20, https://izlik.org/JA77SW38JN.
Vancouver
1.Aysel Aydın, Uğur Yuvanç, Jale Cordan. Novel Approaches in Pharmacological Therapy of Heart Failure: Supression of Neuroendocrihe and Immune Response. Journal of Uludağ University Medical Faculty [Internet]. 2002 Sep. 1;28(3):115-20. Available from: https://izlik.org/JA77SW38JN

ISSN: 1300-414X, e-ISSN: 2645-9027

Creative Commons License
Journal of Uludag University Medical Faculty is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
2023